Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion-Reference-Cited by-同舟云学术

Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion

Published:2010-03 Issue:3 Volume:41 Page:461-465
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Mori Etsuro¹,Minematsu Kazuo¹,Nakagawara Jyoji¹,Yamaguchi Takenori¹,Sasaki Makoto¹,Hirano Teruyuki¹

Affiliation:

1. From the Department of Behavioral Neurology and Cognitive Neuroscience (E.M.), Tohoku University Graduate School of Medicine, Sendai, Japan; Cerebrovascular Division (K.M.), National Cardiovascular Center, Suita, Japan; the Department of Neurosurgery and Stroke Center (J.N.), Nakamura Memorial Hospital, Sapporo, Japan; the National Cardiovascular Center (T.Y.), Suita, Osaka, Japan; Advanced Medical Research Center (M.S.), Iwate Medical University, Morioka, Japan; and the Department of Neurology (T.H...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference19 articles.

1. Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset

2. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

3. Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke

4. Yamaguchi T Kikuchi H Hayakawa T. Clinical efficacy and safety of intravenous tissue plasminogen activator in acute embolic stroke: a randomized double-blind dose-comparison study of duteplase. In: Yamaguchi T Mori E Minematsu K del Zoppo GJ eds. Thrombolytic Therapy in Acute Ischemic Stroke III. Tokyo: Springer-Verlag; 1995: 223–229.

5. Tissue Plasminogen Activator for Acute Ischemic Stroke

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Intracranial Hemorrhage After Endovascular Treatment for Medium Vessel Occlusion;Neurosurgery;2024-09-09

2. Role of Neuroprotective Approaches in the Recanalization Era;Stroke;2024-07

3. Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis;Molecular Neurobiology;2024-06-03

4. Improvement of Functional Outcomes in Patients with Stroke who Received Alteplase for Over 15 Years: Japan Stroke Data Bank;Journal of Atherosclerosis and Thrombosis;2024-01-01

5. Efficacy and safety of intravenous thrombolytic therapy in patients over eighty years;International Journal of Neuroscience;2023-10-24